Dr. Bernstein received her PhD in Psychology from Columbia University in New York. She has been working at the Princess Margaret Cancer Centre since 2006. She is an Assistant Professor in the Department of Psychiatry at the University of Toronto. Her clinical practice includes neuropsychological assessment as well as individual and group psycho-educational interventions designed to teach patients self-management skills to better cope with cognitive dysfunction during and following cancer diagnosis and treatment.
Lori J Bernstein
Dr. Bernstein’s research interests focus on better understanding and characterizing the cognitive changes that cancer and/or its treatment has on people, both in the short and long term, and ways to help improve functioning.
Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review.
Breast Cancer Res Treat. 2017 Jul 13;:
J Drugs Dermatol. 2016 Nov 01;15(11):1420-1426
J Clin Oncol. 2016 Jan 20;34(3_suppl):199
J Clin Oncol. 2016 Jan 20;34(3_suppl):140
Curr Opin Support Palliat Care. 2016 Dec 26;:
Intraindividual Variability in Reaction Time Before and After Neoadjuvant Chemotherapy in Women Diagnosed with Breast Cancer.
Psychooncology. 2016 Dec 21;:
Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer.
BMC Cancer. 2016;16(1):291
Pretreatment Differences in Intraindividual Variability in Reaction Time between Women Diagnosed with Breast Cancer and Healthy Controls.
J Int Neuropsychol Soc. 2016 Mar 10;:1-10
J Int Neuropsychol Soc. 2014 Apr;20(4):351-6
J Int Neuropsychol Soc. 2014 Apr;20(4):380-90